NCT00453622View on ClinicalTrials.gov

RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D

CompletedOBSERVATIONAL
Enrollment

222

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Heart Failure
Interventions
DEVICE

Cardiac Resynchronization Therapy-Defibrillator

Implantation of a CRT-D device

Trial Locations (1)

15240

Veterans' Adminstration Pittsburgh Healthcare System, Pittsburgh

Sponsors
All Listed Sponsors
collaborator

VA Pittsburgh Healthcare System

FED

lead

Abbott Medical Devices

INDUSTRY

NCT00453622 - RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D | Biotech Hunter | Biotech Hunter